Division of Pediatric Allergy and Immunology, Department of Pediatrics, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Division of Pediatric Allergy and Immunology, Department of Pediatrics, SBU Istanbul Cemil Tascioglu City Hospital, Istanbul, Turkey.
Int Arch Allergy Immunol. 2023;184(1):33-42. doi: 10.1159/000526981. Epub 2022 Oct 25.
Ibuprofen is the most common culprit drug causing nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity in children. We aimed to evaluate the frequency, clinical characteristics, and risk factors of confirmed ibuprofen allergy in children presenting with a history of suspected immediate type ibuprofen-induced hypersensitivity reactions.
We evaluated 50 (35 M, 15 F) children with a median age of 7 years, who were referred to our clinic with suspected immediate ibuprofen hypersensitivity. Patients were subjected to a diagnostic work up including drug provocation tests (DPTs) with the culprit drug. Reactions were classified according to the European Academy of Allergy and Clinical Immunology Task Force recommendations for pediatric patients. Proven ibuprofen allergic patients underwent DPT to find a safe alternative drug.
Ibuprofen allergy was confirmed in 34% (n: 17) of children; 9 patients were diagnosed by DPTs and 8 patients diagnosed based on their histories. Angioedema was the most common clinical manifestation (n: 30, 60%). Among patients with proven ibuprofen allergy, 7 of them were classified as cross-intolerant. Cross-intolerance reactions were further classified as NSAID-exacerbated cutaneous disease (n = 1) and NSAID-induced urticaria/angioedema/anaphylaxis (n = 6). As an alternative drug, paracetamol was safely tolerated, whereas 1 patient developed angioedema and urticaria with nimesulide. Older age and male gender were identified as independent risk factors for immediate-type ibuprofen allergy.
DPTs should be performed to confirm or exclude ibuprofen allergy in children and to find safe alternative drugs. Male gender and older age are risk factors for ibuprofen allergy. NSAID-induced hypersensitivity reactions in the pediatric population cannot be well defined using the adult classification system.
布洛芬是导致儿童非甾体抗炎药(NSAID)过敏反应的最常见元凶药物。我们旨在评估有疑似即时型布洛芬诱导过敏反应病史的儿童中,经确认的布洛芬过敏的频率、临床特征和危险因素。
我们评估了 50 名(35 名男性,15 名女性)中位年龄为 7 岁的儿童,他们因疑似即时型布洛芬过敏反应而被转介至我们的诊所。患者接受了包括可疑元凶药物的药物激发试验(DPT)在内的诊断性检查。根据欧洲变态反应与临床免疫学学会(EAACI)儿童患者推荐的建议,对反应进行分类。经确认的布洛芬过敏患者接受 DPT 以寻找安全的替代药物。
34%(n:17)的儿童被确诊为布洛芬过敏;9 名患者通过 DPT 诊断,8 名患者根据病史诊断。血管性水肿是最常见的临床表现(n:30,60%)。在已确诊的布洛芬过敏患者中,有 7 名患者被归类为交叉不耐受。交叉不耐受反应进一步分为 NSAID 加重的皮肤疾病(n=1)和 NSAID 诱导的荨麻疹/血管性水肿/过敏反应(n=6)。作为替代药物,对乙酰氨基酚可安全耐受,而 1 名患者使用尼美舒利时出现血管性水肿和荨麻疹。年龄较大和男性被确定为即时型布洛芬过敏的独立危险因素。
应进行 DPT 以确认或排除儿童对布洛芬的过敏,并找到安全的替代药物。男性和年龄较大是布洛芬过敏的危险因素。儿童人群中的 NSAID 诱导的过敏反应不能使用成人分类系统来很好地定义。